The 12 Hallmarks of Aging in Dogs, Explained
Read full insightVitamin B12 for Dogs
By La Petite Labs Editorial 14 min read
References
Numbered references identify the sources used for specific claims. Read the study design, species and evidence boundaries alongside each finding.
-
Toresson L and colleagues. Effects of oral versus parenteral cobalamin supplementation on methylmalonic acid and homocysteine concentrations in dogs with chronic enteropathies and low cobalamin concentrations. Study design/context: Randomized route comparisonSpecies/context: DogsEvidence boundary: MMA decreased with either route; the 2018 serum report used the same dogs.↩ 1 · ↩ 2
-
Chang CH and colleagues. Effect of oral or injectable supplementation with cobalamin in dogs with hypocobalaminemia caused by chronic enteropathy or exocrine pancreatic insufficiency. Study design/context: Randomized treatment trialSpecies/context: DogsEvidence boundary: 46 completers with intestinal or pancreatic disease; outcomes differed by marker.↩ 1 · ↩ 2
-
Dor C and colleagues. Efficacy and tolerance of oral versus parenteral cyanocobalamin supplement in hypocobalaminaemic dogs with chronic enteropathy: a controlled randomised open-label trial. Study design/context: Randomized open-label trialSpecies/context: DogsEvidence boundary: 19 completers from 37 enrolled; includes severe enteropathy.↩
-
Batt RM and Horadagoda NU. Gastric and pancreatic intrinsic factor-mediated absorption of cobalamin in the dog. Study design/context: Intestinal uptake experimentSpecies/context: DogsEvidence boundary: Direct intrinsic-factor physiology in anesthetized dogs.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4
-
Simpson KW and colleagues. Effect of exocrine pancreatic insufficiency on cobalamin absorption in dogs. Study design/context: Experimental pancreatic insufficiencySpecies/context: DogsEvidence boundary: Enzyme treatment and B12 absorption were distinct in this model.↩
-
Berghoff N and colleagues. Serum cobalamin and methylmalonic acid concentrations in dogs with chronic gastrointestinal disease. Study design/context: Observational biomarker studySpecies/context: DogsEvidence boundary: Low blood B12 and raised MMA did not identify identical groups.↩ 1 · ↩ 2 · ↩ 3
-
Heilmann RM and colleagues. ACVIM-endorsed statement: Consensus statement and systematic review on guidelines for the diagnosis and treatment of chronic inflammatory enteropathy in dogs. Study design/context: Consensus and systematic reviewSpecies/context: DogsEvidence boundary: Current enteropathy guidance; not a new treatment trial.↩ 1 · ↩ 2 · ↩ 3
-
Texas A&M Gastrointestinal Laboratory. Cobalamin Information. Study design/context: Clinical laboratory guidanceSpecies/context: DogsEvidence boundary: Treatment timing and maintenance depend on the clinical plan.↩ 1 · ↩ 2 · ↩ 3
-
Hyland K and Gollakner R. Cyanocobalamin (B12 or Cobalamin). Study design/context: Veterinary client guidanceSpecies/context: Companion animalsEvidence boundary: Cyanocobalamin administration, reactions and medicine cautions.↩ 1 · ↩ 2 · ↩ 3
-
Sanderson SL. Nutritional Requirements of Small Animals. Study design/context: Veterinary nutrition referenceSpecies/context: Dogs and catsEvidence boundary: Nutrition and B12 function; no added-energy trial.↩ 1 · ↩ 2 · ↩ 3
-
U.S. Food and Drug Administration. “Complete and Balanced” Pet Food. Study design/context: Food-label guidanceSpecies/context: Dogs and catsEvidence boundary: Explains nutritional adequacy statements.↩ 1 · ↩ 2
-
U.S. Food and Drug Administration. Paws Off Xylitol; It's Dangerous for Dogs. Study design/context: Ingredient safety guidanceSpecies/context: DogsEvidence boundary: Xylitol can occur in human vitamins and supplements.↩
-
Stanley E and colleagues. Relationship between cobalamin and folate deficiencies and anemia in dogs. Study design/context: Observational clinical studySpecies/context: DogsEvidence boundary: Human anemia patterns did not routinely apply.↩
-
Reactome. MUT isomerises L-MM-CoA to SUCC-CoA. Study design/context: Curated reactionSpecies/context: Human pathway; canine orthologueEvidence boundary: Adenosylcobalamin-dependent nutrient processing.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4
-
Reactome. MTR transfers CH3 from MeCbl to HCYS. Study design/context: Curated reactionSpecies/context: Human pathway; canine orthologueEvidence boundary: Methylcobalamin-dependent transfer in methionine synthesis.↩ 1 · ↩ 2 · ↩ 3
-
Reactome. Complex I oxidises NADH to NAD+, reduces CoQ to CoQH2. Study design/context: Curated reactionSpecies/context: Human pathway; canine orthologueEvidence boundary: NADH-to-CoQ electron transfer; no combination trial.↩
-
Fletcher RS and colleagues. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. Study design/context: Cell and animal experimentsSpecies/context: Mouse cells and miceEvidence boundary: NR-to-NAD chemistry; not a canine study.↩
-
Toresson L and colleagues. The Intestinal Microbiome in Dogs with Chronic Enteropathies and Cobalamin Deficiency or Normocobalaminemia—A Comparative Study. Study design/context: Microbiome comparison and follow-upSpecies/context: DogsEvidence boundary: Low-B12 subgroup overlaps the earlier route-comparison cohort.↩
-
La Petite Labs. Hollywood Elixir product facts and directions. Study design/context: Manufacturer declarationsSpecies/context: Dogs and catsEvidence boundary: Current composition and directions; active B12 amount basis unresolved.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4
-
La Petite Labs. Hollywood Elixir ingredient guide. Study design/context: Ingredient declarationsSpecies/context: Dogs and catsEvidence boundary: Current forms and amounts; no finished-product treatment evidence.↩ 1 · ↩ 2 · ↩ 3
Keep exploring
What would you like to understand next?
Search practical guides about healthy aging, cellular energy, ingredients, and daily support for dogs.

